These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8839165)

  • 21. Interleukin-12: basic principles and clinical applications.
    Trinchieri G; Scott P
    Curr Top Microbiol Immunol; 1999; 238():57-78. PubMed ID: 10087650
    [No Abstract]   [Full Text] [Related]  

  • 22. Prospects for a nonliving vaccine against schistosomiasis based on cell-mediated immune resistance mechanisms.
    James SL; Pearce EJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():121-3. PubMed ID: 3151085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Will the sunscreens of the future contain interleukin-12?
    Senior K
    Lancet; 2001 Dec; 358(9296):1878. PubMed ID: 11741633
    [No Abstract]   [Full Text] [Related]  

  • 24. Induction of protective immunity and modulation of granulomatous hypersensitivity in mice using PIII, an anionic fraction of Schistosoma mansoni adult worm.
    Hirsch C; Zouain CS; Alves JB; Goes AM
    Parasitology; 1997 Jul; 115 ( Pt 1)():21-8. PubMed ID: 9280892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
    Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
    Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing the Production of Male Schistosoma mansoni Cercariae for a Controlled Human Infection Model.
    Janse JJ; Langenberg MCC; Kos-Van Oosterhoud J; Ozir-Fazalalikhan A; Brienen EAT; Winkel BMF; Erkens MAA; van der Beek MT; van Lieshout L; Smits HH; Webster BL; Zandvliet ML; Verbeek R; Westra IM; Meij P; Visser LG; van Diepen A; Hokke CH; Yazdanbakhsh M; Roestenberg M
    J Infect Dis; 2018 Aug; 218(7):1142-1146. PubMed ID: 29905805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-12 and protective immunity to schistosomes.
    Mountford AP; Shires VL; Anderson S
    Braz J Med Biol Res; 1998 Jan; 31(1):163-9. PubMed ID: 9686195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
    Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
    Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12.
    Mackova J; Kutinova L; Hainz P; Krystofova J; Sroller V; Otahal P; Gabriel P; Nemeckova S
    Int J Oncol; 2004 Jun; 24(6):1581-8. PubMed ID: 15138603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiated antitumor effects of interleukin 12 and interferon alpha against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Gołab J; Jakóbisiak M
    Neoplasma; 2001; 48(5):358-61. PubMed ID: 11845979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma and IL-12 plasmid DNAs as vaccine adjuvant in a murine model of grass allergy.
    Kumar M; Behera AK; Hu J; Lockey RF; Mohapatra SS
    J Allergy Clin Immunol; 2001 Sep; 108(3):402-8. PubMed ID: 11544460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
    El Ridi R; Tallima H
    J Parasitol; 2013 Apr; 99(2):194-202. PubMed ID: 22985345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation.
    Siddiqui AA; Phillips T; Charest H; Podesta RB; Quinlin ML; Pinkston JR; Lloyd JD; Pompa J; Villalovos RM; Paz M
    Vaccine; 2003 Jun; 21(21-22):2882-9. PubMed ID: 12798631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
    James SL; Pearce EJ
    J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aluminum hydroxide associated to Schistosoma mansoni 22.6 kDa protein abrogates partial protection against experimental infection but not alter interleukin-10 production.
    Pacífico LG; Fonseca CT; Barsante MM; Cardoso LS; Araújo MI; Oliveira SC
    Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():365-8. PubMed ID: 17308799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.
    Mossallam SF; Amer EI; Ewaisha RE; Khalil AM; Aboushleib HM; Bahey-El-Din M
    BMC Infect Dis; 2015 Mar; 15():147. PubMed ID: 25887456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-12 may be useful for hepatitis C.
    TreatmentUpdate; 2001 Sep; 13(5):4-5. PubMed ID: 11768862
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of recombinant protein r140, a polypeptide segment of tegumental glycoprotein Sm25, as a defined antigen vaccine against Schistosoma mansoni.
    Suri PK; Goldberg M; Madikizela M; Petzke MM; Bungiro RD; Davies SJ; Chakraborty B; Nguyen KB; McCray JW; Knopf PM
    Parasite Immunol; 1997 Nov; 19(11):515-29. PubMed ID: 9427998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.